Our findings illuminate a potential mechanism that underlies the oncogenic effect of LINC00301 on NSCLC and reveal that LINC00301 may be a valuable biomarker and probable therapeutic target in NSCLC. This evidence concerns the gene LINC00301 and non-small cell lung carcinoma.